LIVINGCELL ApS: Financial statements 2022
CVR: 27205607
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
LIVINGCELL ApS (CVR 27205607) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 326,126 and a net result of DKK 251,431 compared with DKK 281,640 the year before. That is a decrease of 10.7% compared with the year before. Equity in the 2022 report amounted to DKK 387,275. The solvency ratio was 63.6%.
- Gross Profit
- DKK 326,126
- Profit/Loss
- DKK 251,431
- Equity
- DKK 387,275
- Total Assets
- DKK 608,948
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 326 t. | 251 t. | 387 t. | - |
| 2021 | - | 365 t. | 282 t. | 416 t. | - |
| 2020 | - | 298 t. | 228 t. | 362 t. | - |
| 2019 | - | 669 t. | 516 t. | 649 t. | - |
| 2018 | - | 894 t. | 693 t. | 823 t. | - |
Official annual report
Keep an eye on LIVINGCELL ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout LIVINGCELL ApS
LIVINGCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Anders Bek-Pedersen. The board consists of Anders Bek-Pedersen (chair). The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 0 employees (2004). In 2025, the company reported a gross profit of DKK -13,500 and a net result of DKK -6,542 compared with DKK -17,604 the year before. Equity in the 2025 report amounted to DKK 115,908.